Susan L. Pendland

2.1k total citations
46 papers, 1.4k citations indexed

About

Susan L. Pendland is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Susan L. Pendland has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 15 papers in Molecular Medicine and 12 papers in Infectious Diseases. Recurrent topics in Susan L. Pendland's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Susan L. Pendland is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Susan L. Pendland collaborates with scholars based in United States, Belgium and Peru. Susan L. Pendland's co-authors include Gail B. Mahady, Zhi Lu, Larry H. Danziger, Lucas R. Chadwick, Chad R. Messick, Birgit M. Dietz, Daniel G. Fabricant, Frank A. Hamill, Manjunath P. Pai and Norman R. Farnsworth and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Susan L. Pendland

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan L. Pendland United States 20 298 283 259 258 238 46 1.4k
Julio G. Prieto Spain 26 388 1.3× 152 0.5× 540 2.1× 305 1.2× 95 0.4× 89 2.3k
Ana I. Álvarez Spain 29 509 1.7× 122 0.4× 740 2.9× 375 1.5× 263 1.1× 92 3.0k
Chien‐Fang Peng Taiwan 23 147 0.5× 224 0.8× 502 1.9× 110 0.4× 225 0.9× 62 1.5k
Pouya Hassandarvish Malaysia 29 277 0.9× 492 1.7× 719 2.8× 422 1.6× 430 1.8× 67 2.9k
Sujata G. Dastidar India 25 317 1.1× 265 0.9× 829 3.2× 146 0.6× 140 0.6× 62 1.6k
Paola Molicotti Italy 26 210 0.7× 113 0.4× 444 1.7× 112 0.4× 208 0.9× 79 1.7k
Roger L. White United States 22 620 2.1× 565 2.0× 378 1.5× 72 0.3× 146 0.6× 52 2.1k
Wanda Reygaert United States 8 157 0.5× 436 1.5× 470 1.8× 85 0.3× 147 0.6× 15 1.9k
Tadakatsu Shimamura Japan 26 193 0.6× 136 0.5× 799 3.1× 218 0.8× 461 1.9× 65 3.5k
Yellela S.R. Krishnaiah India 28 101 0.3× 196 0.7× 233 0.9× 103 0.4× 222 0.9× 77 2.5k

Countries citing papers authored by Susan L. Pendland

Since Specialization
Citations

This map shows the geographic impact of Susan L. Pendland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Pendland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Pendland more than expected).

Fields of papers citing papers by Susan L. Pendland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Pendland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Pendland. The network helps show where Susan L. Pendland may publish in the future.

Co-authorship network of co-authors of Susan L. Pendland

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Pendland. A scholar is included among the top collaborators of Susan L. Pendland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Pendland. Susan L. Pendland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kapur, R. L., Elmer Y. Tu, Susan L. Pendland, Richard G. Fiscella, & Joel Sugar. (2006). The Effect of Temperature on the Antimicrobial Activity of Optisol-GS. Cornea. 25(3). 319–324. 19 indexed citations
4.
Mahady, Gail B., Susan L. Pendland, Frank A. Hamill, et al.. (2005). In Vitro susceptibility ofHelicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytotherapy Research. 19(11). 988–991. 173 indexed citations
5.
Schriever, Christopher, Susan L. Pendland, John P. Quinn, et al.. (2004). Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin at 750 Milligrams and Various Doses of Metronidazole in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 48(12). 4597–4605. 24 indexed citations
6.
Mahady, Gail B., et al.. (2004). Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori.. PubMed. 23(5A). 3699–702. 146 indexed citations
7.
Mahady, Gail B., et al.. (2003). In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytotherapy Research. 17(3). 217–221. 102 indexed citations
8.
Jung, Rose, Susan L. Pendland, & Steven J. Martin. (2003). Effect of Perfluorooctyl Bromide on Bacterial Growth. Chemotherapy. 49(1-2). 1–7. 2 indexed citations
9.
Neuhauser, Melinda M., et al.. (2003). In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 47(3). 1132–1134. 6 indexed citations
10.
Graham, James G., et al.. (2003). Antimycobacterial evaluation of Peruvian plants. Phytomedicine. 10(6-7). 528–535. 22 indexed citations
11.
Pendland, Susan L., et al.. (2002). Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. Diagnostic Microbiology and Infectious Disease. 44(1). 59–61. 5 indexed citations
12.
Pendland, Susan L., et al.. (2002). In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis. Diagnostic Microbiology and Infectious Disease. 43(2). 149–156. 6 indexed citations
13.
Neuhauser, Melinda M., et al.. (2001). Postantibiotic Effects of ABT-773 and Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 45(12). 3613–3615. 4 indexed citations
14.
Garey, Kevin W., et al.. (2001). Cunninghamella bertholletiae Infection in a Bone Marrow Transplant Patient: Amphotericin Lung Penetration, MIC Determinations, and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7). 855–860. 25 indexed citations
15.
Pendland, Susan L., et al.. (2000). In Vitro Activities of a New Ketolide, ABT-773, Alone and in Combination with Amoxicillin, Metronidazole, or Tetracycline against Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 44(9). 2518–2520. 8 indexed citations
16.
Martin, Steven J., et al.. (1998). Levofloxacin and Sparfloxacin: New Quinolone Antibiotics. Annals of Pharmacotherapy. 32(3). 320–336. 44 indexed citations
17.
Messick, Chad R., et al.. (1998). In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci. Diagnostic Microbiology and Infectious Disease. 32(2). 95–99. 1 indexed citations
18.
Martin, Steven J., Susan L. Pendland, Connie L. Chen, Paul C. Schreckenberger, & Larry H. Danziger. (1997). In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: Enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagnostic Microbiology and Infectious Disease. 29(3). 167–171. 8 indexed citations
19.
Messick, Chad R. & Susan L. Pendland. (1997). In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. Diagnostic Microbiology and Infectious Disease. 29(3). 203–205. 17 indexed citations
20.
Fiscella, Richard G., et al.. (1997). Polyhexamethylene Biguanide (PHMB) in the Treatment of Experimental Fusarium Keratomycosis. Cornea. 16(4). 447???449–447???449. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julio G. Prieto Breakdown of academic impact, for papers by Ana I. Álvarez Breakdown of academic impact, for papers by Chien‐Fang Peng Breakdown of academic impact, for papers by Pouya Hassandarvish Breakdown of academic impact, for papers by Sujata G. Dastidar Breakdown of academic impact, for papers by Paola Molicotti Breakdown of academic impact, for papers by Roger L. White Breakdown of academic impact, for papers by Wanda Reygaert Breakdown of academic impact, for papers by Tadakatsu Shimamura Breakdown of academic impact, for papers by Yellela S.R. Krishnaiah
Rankless by CCL
2026